Table 1.
Baseline demographics of all patients and those who completed the study
| Demographic | All Patients(n = 59) | Patients Who Completed the Study(n = 43) |
|---|---|---|
| Age (yr; mean ± SD) | 58.4 ± 16.1 | 58.4 ± 15.6 |
| Gender (F:M) | 17:42 | 10:32 |
| Ethnicity (n [%]) | ||
| white | 53 (89.8) | 37 (88.1) |
| Afro-Caribbean | 5 (8.5) | 4 (9.5) |
| Asian | 1 (1.7) | 1 (2.4) |
| Diabetes (n [%]) | 19 (32.2) | 13 (31.0) |
| Stoke comorbidity score | ||
| low | 16 (27.1) | 13 (31.0) |
| medium | 29 (49.2) | 22 (52.4) |
| high | 14 (23.7) | 7 (16.7) |
| SGA (n [%]) | ||
| A | 50 (84.7) | 36 (85.7) |
| B | 9 (15.3) | 6 (14.3) |
| Height (m; mean ± SD) | 1.71 ± 0.09 | 1.72 ± 0.09 |
| Weight post-HD (kg; mean ± SD) | 78.5 ± 18.5 | 79.1 ± 18.9 |
| Clinical dry weight (kg; mean ± SD) | 78.4 ± 18.5 | 78.9 ± 18.9 |
| BMI (mean ± SD) | 26.7 ± 5.4 | 26.5 ± 5.7 |
SGA, subjective global assessment.